Palisade Bio (PALI) Total Debt (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 256.06% |
| Jun 30, 2025 | -4.35% |
| Jun 30, 2024 | 4.20% |
| Mar 31, 2024 | 0.00% |
| Mar 31, 2017 | -31.70% |
| Dec 31, 2016 | -23.27% |
| Sep 30, 2016 | -18.22% |
| Jun 30, 2016 | -15.78% |
| Mar 31, 2016 | -11.55% |
| Dec 31, 2015 | -12.72% |
| Sep 30, 2015 | 1.12% |
| Jun 30, 2015 | 1.11% |
| Mar 31, 2015 | 1.11% |
| Dec 31, 2014 | 236.46% |
| Sep 30, 2014 | -58.99% |
| Jun 30, 2014 | -9.57% |
| Mar 31, 2014 | -8.51% |
| Dec 31, 2013 | 10.38% |
| Sep 30, 2013 | -8.24% |
| Jun 30, 2013 | 0.62% |